FDA approves Rextovy, a third nonprescription naloxone nasal spray for opioid overdoses

Дата публикации: 25-06-2026 17:07:29

The FDA approved another over-the-counter intranasal naloxone product as an emergency treatment for opioid overdoses, the agency recently announced.The product, 4 mg Rextovy (naloxone hydrochloride, Amphastar Pharmaceuticals), is the third to be approved by the FDA for OTC use. Narcan (Emergent BioSolutions) and RiVive (Harm Reduction Therapeutics) were approved in 2023.“Reducing opioid overdose deaths is a top priority for FDA,” Mike Davis MD, PhD, acting director of the FDA’s Center for Drug Evaluation and Research, said in a press release. “Today’s approval of an additional

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	As-Needed Medications in Newborn Opioid Withdrawal	0	7	23-06-2026
2	FDA advisors back approval of mRNA flu shot	5	7	24-06-2026
3	Mysterious request for unapproved drug raising questions about Trump’s health	-2	7	23-06-2026
4	Using Sound Waves, Rambam Doctors Detox Opioid Addict In Just 20 Minutes	7	8	24-06-2026
5	Psychosocial Interventions Plus Buprenorphine for Opioid Abstinence	0	5	23-06-2026
6	Symptom-Based Dosing for Neonatal Opioid Withdrawal Research Summary	0	7	23-06-2026
7	Exklusiv-Interview mit dem Pharma-Unternehmer Dr. Clemens Fischer über die Zulassung seines neuen Rx-Cannabis-Medikaments und den Kampf gegen chronische Schmerzen	0	0	09-06-2026
8	‘Next major revolution’: The rise of targeted oral psoriasis therapies	5	7	23-06-2026
9	Совфед одобрил закон, разрешающий ввоз в РФ медикаментов с наркотическими веществами	0	0	23-12-2019
10	Минздрав поддерживает предложение разрешить выращивать опийный мак для российских лекарств	0	0	15-10-2018

Классификация: Общество. Схожих патентов: 0. Схожих новостей: 10. Тональность: 5. Информативность: 7. Источник: www.healio.com.